Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.

Novo Nordisk has introduced its weight-loss drug Wegovy in the UAE, marking the first international rollout beyond the U.S. This strategic move underscores the company's focus on expanding access to effective weight management solutions in regions with robust healthcare and telehealth systems. The launch is significant as it highlights the growing global demand for innovative obesity treatments, potentially reshaping the landscape for weight-loss medications. Novo Nordisk's approach, guided by local patient needs and healthcare infrastructure, could set a precedent for future international expansions.